BACE Trial Substudy 2 - FarmEc Substudy

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2020

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Azithromycin

From day 1 up to and including day 3: 500 mg azithromycin or placebo PO once a day From day 4 up to and including day 90: 250 mg azithromycin or placebo PO once every 2 days

DRUG

Placebo

Trial Locations (20)

1000

St. Pieterziekenhuis, Brussels

1090

UZ Brussel, Brussels

2020

ZNA Middelheim, Antwerp

2610

St. Augustinus Ziekenhuis, Antwerp

2820

Imelda Ziekenhuis, Bonheiden

3000

UZ Gasthuisberg, Leuven

3500

Jessa Ziekenhuis, Hasselt

4000

CHU Liège, Liège

4960

Clinique Reine Astrid, Malmedy

5000

Clinique Sainte-Elisabeth, Namur

5530

CHU Mont-Godinne, Yvoir

6060

Grand Hôpital de Charleroi, Gilly

6110

CHU Charleroi, Charleroi

8000

St. Jan Brugge Ziekenhuis, Bruges

8500

AZ Groeninge Ziekenhuis, Kortrijk

8700

St. Andriesziekenhuis, Tielt

8800

Heilig Hart Ziekenhuis, Roeselare

9000

Maria Middelaresziekenhuis, Ghent

UZ Gent, Ghent

9300

Onze-Lieve-Vrouwziekenhuis, Aalst

All Listed Sponsors
lead

Wim Janssens

OTHER

NCT02205255 - BACE Trial Substudy 2 - FarmEc Substudy | Biotech Hunter | Biotech Hunter